BE675379A - - Google Patents
Info
- Publication number
- BE675379A BE675379A BE675379A BE675379A BE675379A BE 675379 A BE675379 A BE 675379A BE 675379 A BE675379 A BE 675379A BE 675379 A BE675379 A BE 675379A BE 675379 A BE675379 A BE 675379A
- Authority
- BE
- Belgium
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/39—Heterocyclic compounds having sulfur as a ring hetero atom having oxygen in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US428210A US3400197A (en) | 1965-01-26 | 1965-01-26 | Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE675379A true BE675379A (US07498051-20090303-C00003.png) | 1966-05-31 |
Family
ID=23697978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE675379A BE675379A (US07498051-20090303-C00003.png) | 1965-01-26 | 1966-01-20 |
Country Status (11)
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2321892A1 (fr) * | 1975-08-27 | 1977-03-25 | Akzo Nv | Preparations pharmaceutiques pour l'administration orale renfermant un ester-17b de nandrolone et nouveaux esters-17b de nandrolone |
| WO1998014168A2 (en) * | 1996-09-30 | 1998-04-09 | Alza Corporation | Dosage form providing a sustained and ascending drug release |
| US6919373B1 (en) | 1996-11-12 | 2005-07-19 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
| EP1690531A3 (en) * | 1996-09-30 | 2010-01-20 | Alza Corporation | Dosage form and method for administering drug |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2360796B2 (de) * | 1973-12-06 | 1977-06-02 | Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München | Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm |
| US4013785A (en) * | 1975-03-21 | 1977-03-22 | Bristol-Myers Company | Apap tablet containing fumed silica and process for manufacturing same |
| DE2845326C2 (de) * | 1978-10-18 | 1985-05-23 | Beiersdorf Ag, 2000 Hamburg | Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung |
| US4347244A (en) * | 1979-03-16 | 1982-08-31 | Societe Anonyme Dite: Institut Merieux | Ganglioside containing compositions for treating diarrhea |
| DE3124983A1 (de) * | 1981-06-25 | 1983-01-20 | Meditest Inst Fuer Medizinisch | Arzneiformen zur oralen verabreichung |
| JPS5839618A (ja) * | 1981-09-04 | 1983-03-08 | Chugai Pharmaceut Co Ltd | 持続性積層錠剤 |
| US4443428A (en) * | 1982-06-21 | 1984-04-17 | Euroceltique, S.A. | Extended action controlled release compositions |
| US4704284A (en) * | 1982-08-12 | 1987-11-03 | Pfizer Inc. | Long-acting matrix tablet formulations |
| US4461759A (en) * | 1983-01-03 | 1984-07-24 | Verex Laboratories, Inc. | Constant release rate solid oral dosage formulations of veropamil |
| US4521402A (en) * | 1983-01-03 | 1985-06-04 | Verex Laboratories, Inc. | Constant release rate solid oral dosage formulations of hydrazine |
| US4522804A (en) * | 1983-01-03 | 1985-06-11 | Verex Laboratories, Inc. | Constant release rate solid oral dosage formulations of propranolol |
| US4559222A (en) * | 1983-05-04 | 1985-12-17 | Alza Corporation | Matrix composition for transdermal therapeutic system |
| WO1984004674A1 (en) * | 1983-05-31 | 1984-12-06 | Jang Choong Gook | Dry direct compression compositions for controlled release dosage forms |
| US4590062A (en) * | 1984-04-16 | 1986-05-20 | Tech Trade Corp. | Dry direct compression compositions for controlled release dosage forms |
| AT385654B (de) * | 1984-09-04 | 1988-05-10 | Arcana Chem Pharm | Verfahren zur herstellung von oelhaeltigen zubereitungen in granulatform zur oralen verabreichung |
| GB8518927D0 (en) * | 1985-07-26 | 1985-09-04 | Vincent Processes Ltd | Tablets |
| GB2186485B (en) * | 1986-02-13 | 1988-09-07 | Ethical Pharma Ltd | Slow release formulation |
| US4820523A (en) * | 1986-04-15 | 1989-04-11 | Warner-Lambert Company | Pharmaceutical composition |
| US4708834A (en) * | 1986-05-01 | 1987-11-24 | Pharmacaps, Inc. | Preparation of gelatin-encapsulated controlled release composition |
| US4795642A (en) * | 1986-05-01 | 1989-01-03 | Pharmacaps, Inc. | Gelatin-encapsulated controlled-release composition |
| EP1202745A4 (en) * | 1999-08-16 | 2004-09-22 | Henceforth Hibernia Inc | THERAPEUTIC AND PROPHYLACTIC COMPOSITIONS CONTAINING CATALYTIC BIOMIMETIC SOLIDS AND METHODS OF PREPARING AND USING SAME |
| US6264983B1 (en) | 1999-09-16 | 2001-07-24 | Rhodia, Inc. | Directly compressible, ultra fine acetaminophen compositions and process for producing same |
| GB0008660D0 (en) | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
| CN1268338C (zh) * | 2001-07-06 | 2006-08-09 | 恩德制药公司 | 用作止痛剂的6－羟基羟吗啡酮的口服给药 |
| US20050232995A1 (en) | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
| EP1596835A1 (en) * | 2003-02-19 | 2005-11-23 | H. Lundbeck A/S | Method for preparation of an agglomerate using melt agglomeration |
| EP1601347A1 (en) * | 2003-02-19 | 2005-12-07 | LifeCycle Pharma A/S | Use of a silica or silica derivative as a sorption material |
| US9308164B2 (en) | 2004-06-30 | 2016-04-12 | Sovereign Pharmaceuticals, Llc | Hyoscyamine dosage form |
| EP1835812B1 (de) | 2004-12-27 | 2011-08-17 | Beiersdorf AG | Glycopyrrolat in kosmetischen zubereitungen |
| JP3955868B2 (ja) * | 2004-12-27 | 2007-08-08 | 株式会社キングジム | 書類等の綴じ具 |
| DE102005029386A1 (de) * | 2005-06-23 | 2007-01-11 | Beiersdorf Ag | Wirkstoffkombinationen aus Glycopyrroniumbromid und einem oder mehreren Hydrokolloiden |
| US9005652B2 (en) * | 2006-07-25 | 2015-04-14 | Wyeth | Chewable tablet containing phenylephrine |
| DE102006046358B3 (de) * | 2006-09-28 | 2007-11-29 | Thüringisches Institut für Textil- und Kunststoff-Forschung e.V. | Verfahren zur Herstellung von funktionellen cellulosischen Formkörpern |
| AR065439A1 (es) | 2007-02-23 | 2009-06-10 | Gilead Sciences Inc | Derivados de tiazoles 1,3 no condensados,composiciones farmaceuticas que los contienen y usos como agentes antivirales, en particular anti hiv. |
| ES2553897T3 (es) * | 2008-05-02 | 2015-12-14 | Gilead Sciences, Inc. | El uso de partículas de vehículo sólido para mejorar la procesabilidad de un agente farmacéutico |
| AU2011346757B2 (en) | 2010-12-22 | 2015-08-20 | Purdue Pharma L.P. | Encased tamper resistant controlled release dosage forms |
| JP5638151B2 (ja) | 2010-12-23 | 2014-12-10 | パーデュー、ファーマ、リミテッド、パートナーシップ | 不正加工抵抗性の（ｔａｍｐｅｒｒｅｓｉｓｔａｎｔ）固形経口剤形 |
| US10751287B2 (en) | 2013-03-15 | 2020-08-25 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2793979A (en) * | 1953-03-30 | 1957-05-28 | Smith Kline French Lab | Method of making a sustained release pharmaceutical tablet and product of the method |
| US2951791A (en) * | 1959-08-31 | 1960-09-06 | American Cyanamid Co | Use of calcium silicate in tablet compressing |
| US2951792A (en) * | 1959-11-18 | 1960-09-06 | Smith Kline French Lab | Sustained release pharmaceutical tablets |
| FR280067A (US07498051-20090303-C00003.png) * | 1960-11-17 | |||
| US3148124A (en) * | 1962-06-12 | 1964-09-08 | William E Gaunt | Method of preparing sustained release pharmaceutical tablets |
| US3147187A (en) * | 1962-09-10 | 1964-09-01 | Don Hall Lab | Sustained release pharmaceutical |
-
1965
- 1965-01-26 US US428210A patent/US3400197A/en not_active Expired - Lifetime
- 1965-12-09 GB GB52366/65A patent/GB1113860A/en not_active Expired
- 1965-12-10 NL NL6516147A patent/NL6516147A/xx unknown
- 1965-12-14 NO NO160902A patent/NO119439B/no unknown
- 1965-12-16 IL IL24813A patent/IL24813A/xx unknown
- 1965-12-30 DK DK670965AA patent/DK115350B/da unknown
- 1965-12-30 BR BR176133/65A patent/BR6576133D0/pt unknown
-
1966
- 1966-01-14 ES ES0321779A patent/ES321779A1/es not_active Expired
- 1966-01-18 AT AT44566A patent/AT267068B/de active
- 1966-01-20 BE BE675379A patent/BE675379A/xx unknown
- 1966-01-26 FR FR47277A patent/FR5137M/fr not_active Expired
- 1966-01-26 FR FR47278A patent/FR1465919A/fr not_active Expired
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2321892A1 (fr) * | 1975-08-27 | 1977-03-25 | Akzo Nv | Preparations pharmaceutiques pour l'administration orale renfermant un ester-17b de nandrolone et nouveaux esters-17b de nandrolone |
| WO1998014168A2 (en) * | 1996-09-30 | 1998-04-09 | Alza Corporation | Dosage form providing a sustained and ascending drug release |
| WO1998014168A3 (en) * | 1996-09-30 | 1998-07-30 | Alza Corp | Dosage form providing a sustained and ascending drug release |
| EP1690531A3 (en) * | 1996-09-30 | 2010-01-20 | Alza Corporation | Dosage form and method for administering drug |
| US6919373B1 (en) | 1996-11-12 | 2005-07-19 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
| US6930129B2 (en) | 1996-11-12 | 2005-08-16 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
| US8163798B2 (en) | 1996-11-12 | 2012-04-24 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
| US8629179B2 (en) | 1996-11-12 | 2014-01-14 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
| US9000038B2 (en) | 1996-11-12 | 2015-04-07 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
| US9029416B2 (en) | 1996-11-12 | 2015-05-12 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
| US9144549B2 (en) | 1996-11-12 | 2015-09-29 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
Also Published As
| Publication number | Publication date |
|---|---|
| US3400197A (en) | 1968-09-03 |
| NO119439B (US07498051-20090303-C00003.png) | 1970-05-19 |
| DK115350B (da) | 1969-09-29 |
| FR1465919A (fr) | 1967-01-13 |
| NL6516147A (US07498051-20090303-C00003.png) | 1966-07-27 |
| AT267068B (de) | 1968-12-10 |
| BR6576133D0 (pt) | 1973-09-06 |
| GB1113860A (en) | 1968-05-15 |
| ES321779A1 (es) | 1966-06-16 |
| IL24813A (en) | 1969-06-25 |
| FR5137M (US07498051-20090303-C00003.png) | 1967-06-05 |
